164 related articles for article (PubMed ID: 17907292)
1. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.
Akkaya O; Kiyici M; Yilmaz Y; Ulukaya E; Yerci O
World J Gastroenterol; 2007 Nov; 13(41):5481-5. PubMed ID: 17907292
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.
McCormick SE; Goodman ZD; Maydonovitch CL; Sjogren MH
Am J Gastroenterol; 1996 Aug; 91(8):1516-22. PubMed ID: 8759653
[TBL] [Abstract][Full Text] [Related]
3. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
Reedy DW; Loo AT; Levine RA
Dig Dis Sci; 1998 Sep; 43(9):2156-9. PubMed ID: 9753286
[TBL] [Abstract][Full Text] [Related]
4. Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management.
Gupta RK; Sakhuja P; Majumdar K; Ali S; Srivastava S; Sachdeva S; Sharma BC; Puri AS
Indian J Pathol Microbiol; 2018; 61(3):345-349. PubMed ID: 30004052
[TBL] [Abstract][Full Text] [Related]
5. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.
Luo JC; Hwang SJ; Lai CR; Lu CL; Li CP; Tsay SH; Wu JC; Chang FY; Lee SD
J Gastroenterol Hepatol; 1998 Jul; 13(7):685-90. PubMed ID: 9715418
[TBL] [Abstract][Full Text] [Related]
6. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
7. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
[TBL] [Abstract][Full Text] [Related]
8. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
9. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
10. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
[TBL] [Abstract][Full Text] [Related]
12. Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
Perez RM; Ferreira AS; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
Clin Transplant; 2005 Oct; 19(5):622-5. PubMed ID: 16146553
[TBL] [Abstract][Full Text] [Related]
13. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
14. Pathological evolution of hepatitis C virus-"Healthy carriers".
Sobesky R; Lebray P; Nalpas B; Vallet-Pichard A; Fontaine H; Lagneau JL; Pol S
World J Gastroenterol; 2008 Jun; 14(24):3861-5. PubMed ID: 18609710
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis and patterns of ALT and hepatitis C virus seroconversion in haemodialysis patients with acute hepatitis.
Lampe E; Yoshida CF; De Oliveira RV; Lauer GM; Lewis-Ximenez LL
Nephrology (Carlton); 2008 Jun; 13(3):186-92. PubMed ID: 18315700
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
[TBL] [Abstract][Full Text] [Related]
17. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
[TBL] [Abstract][Full Text] [Related]
19. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
Mathurin P; Moussalli J; Cadranel JF; Thibault V; Charlotte F; Dumouchel P; Cazier A; Huraux JM; Devergie B; Vidaud M; Opolon P; Poynard T
Hepatology; 1998 Mar; 27(3):868-72. PubMed ID: 9500720
[TBL] [Abstract][Full Text] [Related]
20. Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.
Hajarizadeh B; Lamoury FM; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J; Applegate TL;
Virol J; 2016 Feb; 13():32. PubMed ID: 26911712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
